DeutschNewstral
Article
Ppacbiztimes.com on 2022-03-01 02:33
Arcutis share up after earnings report; company reports mounting losses but progress toward FDA approval
Related news
CBD oil product moves toward FDA approvalKTVB- PAmgen’s game-changing lung cancer treatment gains FDA approvalpacbiztimes.com
- PMannKind takes next step in rebuild with new FDA approvalpacbiztimes.com
- PArcutis reports Q1 loss, progress toward product launchpacbiztimes.com
FibroGen CEO Thomas Neff dies suddenly as company drives toward first FDA drug approvalbizjournals.com- Building toward FDA drug approval, Peninsula biotech targets $605M stock offeringbizjournals.com
FDA says it 'will rapidly work toward' approval of Pfizer-BioNTech coronavirus vaccinepost-gazette.com
Ovarian cancer treatment on fast track for FDA approval as chemo alternatives emerge: 'We're making progress'Fox News- GTx receives FDA approvalbizjournals.com
Emergent receives FDA approvalthedailyrecord.com
Nephron gets FDA approvallexingtonchronicle.com
Letter: On FDA approvalAlaska Dispatch News
Lady hoops making progress despite mounting lossesthecantoncitizen.com
Israeli startup gains FDA approvalisraelnationalnews.com- Durham pharma receives FDA approvalbizjournals.com
- PSientra wins new FDA approvalpacbiztimes.com
- Stereotaxis device gets FDA approvalbizjournals.com
Vertex drug gets FDA approvalBoston Herald
‘Female Viagra’ gets FDA approvalFOX 8 News Cleveland
Eton Pharmaceuticals announces FDA approvaldailyherald.com